中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
9期
133-134
,共2页
波立维%泰嘉%冠心病%临床疗效
波立維%泰嘉%冠心病%臨床療效
파립유%태가%관심병%림상료효
Wave d%Tai jia%Coronary heart disease%Clinical curative effect
目的:分析对比波立维和泰嘉治疗冠心病的临床疗效及经济学差异。方法选取2013年3月—2014年5月期间该院收治的冠心病患者80例,随机分为波立维组及泰嘉组。对比分析两组患者的临床疗效、不良反应以及患者的治疗费用。结果在随访1年内,两组患者的临床有效率及不良反应发生情况差异无统计学意义(P>0.05);泰嘉组的治疗费用明显低于波立维组,两组差异具有统计学意义(P<0.05)。结论临床运用波立维及泰嘉治疗冠心病在临床疗效、不良反应基本无区别,但泰嘉的治疗费用明显低于波立维。所以可以用泰嘉代替波立维代替治疗冠心病。
目的:分析對比波立維和泰嘉治療冠心病的臨床療效及經濟學差異。方法選取2013年3月—2014年5月期間該院收治的冠心病患者80例,隨機分為波立維組及泰嘉組。對比分析兩組患者的臨床療效、不良反應以及患者的治療費用。結果在隨訪1年內,兩組患者的臨床有效率及不良反應髮生情況差異無統計學意義(P>0.05);泰嘉組的治療費用明顯低于波立維組,兩組差異具有統計學意義(P<0.05)。結論臨床運用波立維及泰嘉治療冠心病在臨床療效、不良反應基本無區彆,但泰嘉的治療費用明顯低于波立維。所以可以用泰嘉代替波立維代替治療冠心病。
목적:분석대비파립유화태가치료관심병적림상료효급경제학차이。방법선취2013년3월—2014년5월기간해원수치적관심병환자80례,수궤분위파립유조급태가조。대비분석량조환자적림상료효、불량반응이급환자적치료비용。결과재수방1년내,량조환자적림상유효솔급불량반응발생정황차이무통계학의의(P>0.05);태가조적치료비용명현저우파립유조,량조차이구유통계학의의(P<0.05)。결론림상운용파립유급태가치료관심병재림상료효、불량반응기본무구별,단태가적치료비용명현저우파립유。소이가이용태가대체파립유대체치료관심병。
Objective To analyzed wave set peacekeeping tai jia difference in economics and the clinical curative effect of treatment of coronary heart disease (CHD).Methods Between March 2013 and May 2013 in our department to take the 80 cases of patients with coronary heart disease, were randomly divided into wave d and tai jia group. Comparative analysis of two groups of patients with clinical efficacy, adverse reactions, and the patient’s treatment.Results In the follow-up of 1 year, two groups of patients with the clinical effectiveness and adverse reactions occur differences had no statistical significance (P> 0.05); But the costs of treating tai jia group was obviously lower wavelengths, d group, the differences between the two groups have statistical significance (P< 0.05).Conclusion The clinical use of wave vertical dimension and tai jia on the treatment of coronary heart disease in clinical efficacy, So you can use tai jia for wave vertical dimension for treatment of coronary heart disease.